(Q34008796)

30 July 2017

title

Hepcidin levels and their determinants in different types of myelodysplastic syndromes (English)

1 reference

30 July 2017

4

Nicola Martinelli

1 reference

30 July 2017

Valeria Santini

1

1 reference

30 July 2017

Domenico Girelli

2

1 reference

30 July 2017

Alessandro Sanna

3

1 reference

30 July 2017

Lorena Duca

5

1 reference

30 July 2017

Natascia Campostrini

6

1 reference

30 July 2017

Agostino Cortelezzi

7

1 reference

30 July 2017

Michela Corbella

8

1 reference

30 July 2017

Alberto Bosi

9

1 reference

30 July 2017

Gianluigi Reda

10

1 reference

30 July 2017

Oliviero Olivieri

11

1 reference

30 July 2017

Maria Domenica Cappellini

12

1 reference

30 July 2017

language of work or name

English

0 references

publication date

19 August 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

6

1 reference

30 July 2017

issue

8

1 reference

30 July 2017

page(s)

e23109

1 reference

Creative Commons Attribution 4.0 International

30 July 2017

copyright license

start time

19 August 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Hepcidin and disorders of iron metabolism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Two to tango: regulation of Mammalian iron metabolism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Iron homeostasis and the inflammatory response

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Growth differentiation factor 15 in erythroid health and disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Impact of iron overload in myelodysplastic syndromes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Hepcidin assay in serum by SELDI-TOF-MS and other approaches

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Ferritins: a family of molecules for iron storage, antioxidation and more.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical use.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

The World Health Organization (WHO) classification of the myeloid neoplasms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Classification and diagnosis of iron overload

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Perspectives in iron metabolism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

Myelodysplastic Syndromes

5 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023109

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023109

High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023109

Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023109

Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023109

Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023109

Growth differentiation factor 5 regulates cardiac repair after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023109

Non-invasive assessment of hepatic iron stores by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023109

Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023109

Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158762

29 October 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023109

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023109

Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?

21 January 2018

1 reference

12 December 2020

Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin

1 reference

12 December 2020

Hepcidin and iron-loading anemias

1 reference

12 December 2020

Predicting survival and leukemic evolution in patients with myelodysplastic syndrome

1 reference

12 December 2020

Consensus statement on iron overload in myelodysplastic syndromes

1 reference

12 December 2020

Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia

1 reference

12 December 2020

Urinary hepcidin excretion in patients with low grade myelodysplastic syndrome

1 reference

12 December 2020

Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0023109

Identifiers

DOI

1 reference

release_fyxris7n7zgdhkcfabzt6jobmq

30 July 2017

0 references

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fyxris7n7zgdhkcfabzt6jobmq

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3158762

1 reference

30 July 2017

1 reference